Many among the roughly 4,000 abstracts (offered by 1,600 presenters) at the American Heart Association Scientific Sessions 2008 were focused on the setting of acute coronary syndromes (ACS). Two such sessions reviewed below were included among the high-profile Late-Breaking Clinical Trials. A third examined treatment for children with familial hypercholesterolemia.
